Fractional and Microablative CO 2 LASER and Radiofrequency in the Treatment of Genitourinary Syndrome of Menopause: A Descriptive Study
Photobiomodulation, Photomedicine, and Laser Surgery · 2024
DOI: 10.1089/pho.2023.0110 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Photobiomodulation, Photomedicine, and Laser Surgery, 2024. Verfasst von Maria Cristina Caceres Nogueira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. Hauptthemen laut MEDLINE: Lasers, Gas, Menopause, Vagina. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objectives
This study aimed to evaluate the vagina clinically, cytologically, and histologically before and after treating genitourinary syndrome of menopause (GSM) with fractional microablative carbon dioxide LASER (CO 2 L), radiofrequency (RF), and estrogen vaginal cream (CT).
Methods
Women with moderate-to-severe symptoms of GSM, denoted by a GSM Visual analog scale (VAS) score of >4, were eligible for this study. The patients were randomized into treatment groups. In the energy groups, three vulvovaginal applications were administered monthly. The CT group used 0.5 mg vaginal estriol cream for 14 consecutive days, followed by twice a week for 4 months. The follow-up visits occurred 120 days after the beginning of the treatments. The same parameters obtained at the first visit were re-evaluated: GSM VAS score, Incontinence Quality of Life Questionnaire (I-QOL), gynecological examination determining Vaginal Health Index (VHI), vaginal smear for Vaginal Maturation Value (VMV), and vaginal biopsy.
Results
Seventy-one women were included, 48 completed the study and provided adequate samples for analysis (CO 2 L [21 patients], RF [15 patients], and CT [12 patients]). GSM symptoms, I-QOL, and VHI significantly improved after all proposed treatments, with no significant differences between them. VMV did not change after any treatment; however, only 22.9% of the patients presented with cytological atrophy before treatment. Histological vaginal atrophy was identified in 6 (12.5%) pretreated vaginal samples. After the intervention, all histological parameters were normalized, no tissue damage was observed, and no major clinical complications were observed.
Conclusion
CO 2 L and RF seem to be good alternatives to CT for GSM treatment, with no tissue damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
- Department of Pathology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
ORCID-Profile: Carla Dias Oliveira
Zitieren
APA
Caceres Nogueira, M. C., Homem de Mello Bianchi-Ferraro, A. M., Leonor Pereira Campos, M., Dias Oliveira, C., Gracio Ferreira Sartori, M., Di Bella, Z. I. K. J., Logullo, A. F., LARF study group, & Speck, N. M. G. (2024). Fractional and Microablative CO 2 LASER and Radiofrequency in the Treatment of Genitourinary Syndrome of Menopause: A Descriptive Study. Photobiomodulation, Photomedicine, and Laser Surgery. https://doi.org/10.1089/pho.2023.0110
Vancouver
Caceres Nogueira MC, Homem de Mello Bianchi-Ferraro AM, Leonor Pereira Campos M, Dias Oliveira C, Gracio Ferreira Sartori M, Di Bella ZIKJ, et al. Fractional and Microablative CO 2 LASER and Radiofrequency in the Treatment of Genitourinary Syndrome of Menopause: A Descriptive Study. Photobiomodulation, Photomedicine, and Laser Surgery. 2024. doi:10.1089/pho.2023.0110
BibTeX
@article{CaceresNogueira2024,
author = {Caceres Nogueira, Maria Cristina and Homem de Mello Bianchi-Ferraro, Ana Maria and Leonor Pereira Campos, Madalena and Dias Oliveira, Carla and Gracio Ferreira Sartori, Marair and Di Bella, Zsuzsanna Ilona Katalin de Jármy and Logullo, Angela Flavia and LARF study group, LARF study group and Speck, Neila Maria Gois},
title = {Fractional and Microablative CO 2 LASER and Radiofrequency in the Treatment of Genitourinary Syndrome of Menopause: A Descriptive Study},
journal = {Photobiomodulation, Photomedicine, and Laser Surgery},
year = {2024},
doi = {10.1089/pho.2023.0110}
}
EUVIMED